from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1457c/-

LFCtreatmentdescriptionclass of inhibitor

0.080

Amikacinug/mL Amikacintranslation

-1.804

Cap5-10ug/mL Capreomycintranslation

-0.603

Rox10-50 ug/mL Roxithromycintranslation

-0.598

SM2-5 ug/mL Streptomycintranslation

1.632

Tet5-10 ug/mL Tetracyclinetranslation

0.912

Rif0.2-5ug/mL Rifampicintranscription

0.665

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.418

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.731

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.360

CPZ10-50 ug/mL Chlorpromazinerespiration

0.121

Clofazimine10-13 ug/mL Clofaziminerespiration

0.352

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.514

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.818

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.304

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.281

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.789

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.109

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.652

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.237

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.250

KCN5-20 ug/mL Potassium cyaniderespiration

0.368

NaN30.2-2 mM Sodium aziderespiration

-0.163

Nigericin50 uM Nigericinrespiration

0.592

TRC10-150 ug/mL Triclosanrespiration

0.155

TRZ10-25 ug/mL Thioridazinerespiration

-0.196

Valinomycin0.5-10 uM Valinomycinrespiration

0.461

ZnSO42 mM ZnSO4respiration

-0.879

menadione6-10 ug/mL Menadionerespiration

0.374

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.179

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.165

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.238

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.202

NRP_1Non-replicating persistence stage 1dosRassociated

-0.506

Amp0.2mg/mL AmpicillincellWall

0.045

Cephalexin20-100 ug/mL CephalexincellWall

0.284

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.048

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.346

EMB10-20 ug/mL EthambutolcellWall

0.656

Eta12-40 ug/mL EthionamidecellWall

-0.038

INH0.2-0.4 ug/mL IsoniazidcellWall

0.303

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.215

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.373

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.494

BZA0.12 mg/mL BenzamidearomaticAmides

-0.354

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.183

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.337

H2O24 mM hydrogen peroxideDNAdamaging

1.227

Levo10 ug/mL LevofloxacinDNAdamaging

-0.262

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.885

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.275

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.138

UVUV-irradiationDNAdamaging

0.406

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.123

Antimycin12.5-50 ug/mL Antimycin A?

-0.390

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.103

PA_110-50 ug/mL Antitubercular compound PA-1?

0.726

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.033

PA8240.2-2 ug/mL PA-824?

0.513

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.602

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.077

Verapamil50 uM Verapamil?

-0.571

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.126

methoxatin10-20 ug/mL Methoxatin?